AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc.

ACRX
AcelRx Pharmaceuticals, Inc.US flagNASDAQ Global Market
0.86
USD
+0.06
- -
14.58MMarket Cap

AcelRx Pharmaceuticals, Inc. (ACRX) Stock Split History

Learn about AcelRx Pharmaceuticals, Inc.'s most recent 1-for-20 basis stock split on October 26, 2022. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about AcelRx Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2022-10-26
Split Ratio: 1:20
Price Before Split: $0.18
Price After Split: $0.01

Developer API

Get ACRX split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ACRX

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of AcelRx Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2022-10-261:20Yes$0.18$0.01

About AcelRx Pharmaceuticals, Inc.

Company overview and industry information

AcelRx Pharmaceuticals, Inc. (ACRX) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Drug Manufacturers - Specialty & Generic
Go to AcelRx Pharmaceuticals, Inc. Summary

Last updated: 7/5/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.